This guide offers a clear overview for Arizona neurologists considering a sale. We will look at current market dynamics, key financial metrics, and the strategic steps that pave the way for a successful exit. You will learn what sophisticated buyers look for and how to prepare your practice to meet their expectations.
Not sure if selling is right for you? Our advisors can help you understand your options without any pressure.
Selling a medical practice is a significant decision. For neurologists in Arizona, the current market presents a unique opportunity, driven by demographic shifts and high demand for specialized care. This article provides a clear roadmap for navigating the process.
Here s what we ll cover:
* Why Arizona’s neurology market is favorable for sellers right now.
* How to understand your practice’s true value beyond a simple revenue multiple.
* The key stages and considerations for a successful sale.
Market Overview
The climate for selling a neurology practice in Arizona is strong. This is not a matter of luck. It’s a matter of demographics. Arizona s growing and aging population means a higher prevalence of neurological conditions, from neuropathy and dizziness to epilepsy and sleep disorders. This trend directly increases the demand for established neurology practices like yours.
With just under 600 neurologists currently serving the entire state, the demand for services often outpaces the supply. For a practice owner, this imbalance creates significant leverage. Potential buyers, whether they are large hospital groups, private equity-backed platforms, or individual neurologists, recognize this. They are actively seeking well-run practices in the state to meet this growing patient need. This environment makes it a seller’s market, but turning that advantage into a premium valuation requires careful preparation.
Key Considerations
A successful sale goes beyond the final price. It s about finding the right fit for your legacy, your staff, and your personal goals. As you begin to think about a sale, consider these three critical areas:
-
The Buyer’s Profile. A sale to a large hospital system is very different from a sale to a private equity group or another neurologist. One might offer a higher cash-at-close payment, while another might offer an equity partnership that allows you to share in future growth. Defining your ideal successor is the first step in the process. Your goals for clinical autonomy and your staff’s future should guide this decision.
-
Your Transition Plan. How long are you willing to stay on post-sale to ensure a smooth handover? Buyers will expect a transition plan, typically from six months to two years. A well-defined plan not only provides continuity for patients and staff but can also be a key point of negotiation in the deal structure.
-
The Structure of the Deal. The sale is not a single event. It can be structured with earnouts or even an equity rollover, where you retain a stake in the new, larger entity. We find that many physicians value these structures because they offer a potential “second bite of the apple.” This approach can align your financial success with the continued success of the practice you built.
Market Activity
The market is not just theoretically strong; it’s active. For example, we recently saw a neurology and sleep medicine practice with two locations in Arizona and one in Nevada come to market. The practice, established in 2003, generated nearly $3.3 million in gross revenue and over $1.6 million in cash flow (Seller’s Discretionary Earnings).
Initially listed at a higher price, it was later adjusted to an asking price of $3.95 million. This single example tells us a few things. First, multi-location, high-cash-flow neurology practices are highly sought after. Second, the initial pricing and positioning are critical. Understanding how buyers, including non-neurologists, will analyze your financials is key to arriving at a defensible and attractive valuation from the start.
The Sale Process
Selling a practice follows a structured path. Understanding this path is the first step to controlling the outcome. We run a professional process designed to protect your confidentiality and maximize value.
Phase 1: Preparation and Valuation
This is the most important phase, and it happens long before a buyer is ever contacted. It involves getting your financial statements in order, normalizing your earnings to reflect the true profitability of the practice, and developing a compelling narrative about your growth potential. This is also where a formal valuation is conducted to set a defensible asking price. Many owners think they should wait until they are 2-3 years from selling. That s precisely when you should start this work. Buyers pay for proven history, not last-minute potential.
Phase 2: Confidential Marketing
We do not simply “list” your practice. We create a confidential process to approach a curated list of qualified strategic and financial buyers. These potential partners are vetted and must sign a Non-Disclosure Agreement (NDA) before receiving any identifying information. This creates competitive tension to drive up value while your staff and patients remain completely unaware.
Phase 3: Due Diligence and Closing
Once you accept an offer, the buyer will begin due diligence. They will scrutinize your financials, contracts, and operations. This is where many deals encounter problems if the practice is not properly prepared. Our job is to anticipate and organize everything a buyer will request, making the process a final confirmation rather than a new negotiation.
What Is Your Practice Really Worth?
Many physicians hear that specialty practices sell for a multiple of their yearly revenue, perhaps around 1.0x. While this is a common rule of thumb, it is not how sophisticated buyers value a practice. They look deeper, focusing on a metric called Adjusted EBITDA.
EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure of a practice’s cash flow and true profitability. “Adjusted” is the key part of the term. We adjust the numbers by adding back owner-specific expenses that a new owner would not incur, like a personal car lease or a higher-than-market owner salary.
For example, a practice with $500,000 in net income might have a true Adjusted EBITDA of $700,000 after these add-backs. Serious buyers apply a multiple to this higher, more accurate number. For a healthy practice, this multiple might be in the 5x to 7x range, or even higher. This is how we uncover the hidden value in a practice. Most practices are undervalued until their financials are properly normalized and their story is told correctly.
Planning for What Comes Next
The day you close the sale is a beginning, not just an end. How the deal is structured has major implications for your finances and your future role. It is important to think about your ideal exit scenario from the start.
There are three common paths, each with different benefits.
Your Exit Option | What It Means for You | The Main Consideration |
---|---|---|
Clean Exit | You receive full payment at closing and transition out of the practice over a pre-defined period. | This path offers the most certainty and immediate freedom. |
Deal with an Earnout | A portion of your total payment is tied to the practice hitting specific performance goals over the next 1-2 years. | You can often achieve a higher total valuation, but it comes with performance risk. |
Equity Rollover | You re-invest a portion of your sale proceeds (e.g., 20%) back into the new, larger company. | This gives you a stake in future success, offering a potential “second bite of the apple” when the larger entity sells. |
The right path depends entirely on your personal and financial goals. The structure also has major implications for your after-tax proceeds. Planning this strategy in advance, rather than simply reacting to a buyer’s first offer, is one of the most important parts of the entire transition.
Frequently Asked Questions
Why is now a good time to sell a neurology practice in Arizona?
Arizona has a growing and aging population leading to increased demand for neurological services. The supply of neurologists is limited, creating a seller’s market with strong buyer interest from hospital groups, private equity, and individual neurologists.
What key financial metric do sophisticated buyers use to value a neurology practice?
Sophisticated buyers focus on Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) rather than simple revenue multiples. Adjusted EBITDA reflects true cash flow by adding back owner-specific expenses.
What are the main stages in selling a neurology practice in Arizona?
The sale process has three main stages: 1) Preparation and Valuation – organizing financials and setting a defensible asking price; 2) Confidential Marketing – approaching vetted buyers under NDA to create competitive tension; 3) Due Diligence and Closing – buyer scrutinizes financials and operations, followed by deal finalization.
What should I consider about the buyer when selling my neurology practice?
Consider the buyer’s profile, such as whether they are a hospital system, private equity, or another neurologist. This affects deal structure, cash payment, clinical autonomy, and staff future. Defining your ideal successor based on your goals is critical.
What are common exit options when selling a neurology practice and their benefits?
1) Clean Exit: full payment at closing with a transition period, offering certainty and immediate freedom.
2) Deal with Earnout: part of payment depends on future performance, potentially increasing total value but with risk.
3) Equity Rollover: reinvesting a portion into the new company, offering ongoing financial upside and involvement.